JP2022530264A5 - - Google Patents

Info

Publication number
JP2022530264A5
JP2022530264A5 JP2021564486A JP2021564486A JP2022530264A5 JP 2022530264 A5 JP2022530264 A5 JP 2022530264A5 JP 2021564486 A JP2021564486 A JP 2021564486A JP 2021564486 A JP2021564486 A JP 2021564486A JP 2022530264 A5 JP2022530264 A5 JP 2022530264A5
Authority
JP
Japan
Prior art keywords
virus particle
polynucleotide
aav virus
aav
sequence
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2021564486A
Other languages
English (en)
Japanese (ja)
Other versions
JP7788594B2 (ja
JP2022530264A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2020/030427 external-priority patent/WO2020223322A1/en
Publication of JP2022530264A publication Critical patent/JP2022530264A/ja
Publication of JP2022530264A5 publication Critical patent/JP2022530264A5/ja
Application granted granted Critical
Publication of JP7788594B2 publication Critical patent/JP7788594B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2021564486A 2019-04-29 2020-04-29 乳児バッテン病の治療のための髄腔内および静脈内組合せ遺伝子療法 Active JP7788594B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201962840360P 2019-04-29 2019-04-29
US62/840,360 2019-04-29
PCT/US2020/030427 WO2020223322A1 (en) 2019-04-29 2020-04-29 Intrathecal and intravenous combination gene therapy for the treatment of infantile batten disease

Publications (3)

Publication Number Publication Date
JP2022530264A JP2022530264A (ja) 2022-06-28
JP2022530264A5 true JP2022530264A5 (enExample) 2023-05-12
JP7788594B2 JP7788594B2 (ja) 2025-12-19

Family

ID=73029200

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2021564486A Active JP7788594B2 (ja) 2019-04-29 2020-04-29 乳児バッテン病の治療のための髄腔内および静脈内組合せ遺伝子療法

Country Status (12)

Country Link
US (1) US20220193268A1 (enExample)
EP (1) EP3963081A4 (enExample)
JP (1) JP7788594B2 (enExample)
KR (1) KR20220046513A (enExample)
CN (1) CN114269935A (enExample)
AU (1) AU2020264438A1 (enExample)
BR (1) BR112021021632A8 (enExample)
CA (1) CA3138274A1 (enExample)
IL (1) IL287608A (enExample)
MX (1) MX2021013275A (enExample)
SG (1) SG11202111908XA (enExample)
WO (1) WO2020223322A1 (enExample)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2025524569A (ja) * 2022-07-06 2025-07-30 リサーチ インスティチュート アット ネイションワイド チルドレンズ ホスピタル Cln1ポリヌクレオチドのアデノ随伴ウイルス送達
JP2025524636A (ja) * 2022-07-12 2025-07-30 リサーチ インスティチュート アット ネイションワイド チルドレンズ ホスピタル アデノ随伴ウイルス遺伝子療法産物及び方法

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20130010121A (ko) * 2010-03-23 2013-01-25 인트렉손 코포레이션 치료적 단백질을 조건부로 발현하는 벡터,상기 벡터를 포함하는 숙주 세포 및 이의 용도
WO2016100575A1 (en) * 2014-12-16 2016-06-23 Board Of Regents Of The University Of Nebraska Gene therapy for juvenile batten disease
CN109415730A (zh) * 2016-06-13 2019-03-01 北卡罗来纳大学教堂山分校 优化的cln1基因和表达盒以及它们的应用
WO2019011817A1 (en) * 2017-07-08 2019-01-17 Genethon TREATMENT OF SPINAL AMYOTROPHY
WO2019046815A1 (en) * 2017-08-31 2019-03-07 Poseida Therapeutics, Inc. TRANSPOSON SYSTEM AND METHODS OF USE

Similar Documents

Publication Publication Date Title
US20220331409A1 (en) Factor ix gene therapy
JP2022141670A5 (enExample)
JP2022520232A5 (enExample)
JP2025179046A5 (enExample)
J. McCown Adeno-associated virus (AAV) vectors in the CNS
JP2022516283A5 (enExample)
US20250305001A1 (en) Genetic Construct
JP2021500922A5 (enExample)
JP2021533805A5 (enExample)
RU2018145010A (ru) Оптимизированные гены и экспрессионные кассеты cln1, и их применение
JP2025512574A5 (enExample)
JP2022530264A5 (enExample)
JP2022533448A5 (enExample)
JP2023503850A5 (enExample)
JP2022539156A (ja) ヒアルロン酸を用いた眼組織へのaav媒介形質導入の増強
JP2024546103A5 (enExample)
JP2024545507A5 (enExample)
EP3773748A1 (en) Bicistronic aav vectors encoding hexosaminidase alpha and beta-subunits and uses thereof
EP4509606A1 (en) Nucleic acid construct for treating hereditary coagulation factor deficiency and use thereof
CA3178591A1 (en) Immunosuppressive agents and viral delivery re-dosing methods for gene therapy
JP2022530359A5 (enExample)
JP2023526923A5 (enExample)
JP2023536067A5 (enExample)
JP2025504478A5 (enExample)
JP2025503868A5 (enExample)